Public Health
“Antivitamins” could be the cure for antibiotic resistance
The B1 antivitamin helps bacteria kill competing bacteria, leading researchers to suspect it could help us fight antibiotic resistance and superbugs.
Open-source COVID-19 saliva test could be a game changer
SalivaDirect, a COVID-19 saliva test funded by the NBA and NBA players’ union, could be the cheap, accurate testing method the U.S. desperately needs.
Gates Foundation backs a $3 coronavirus vaccine
The Gates Foundation is spending $150 million to help with the manufacturing and distribution of a $3 coronavirus vaccine in lower-income nations.
Is it safe to fly right now? MIT expert weighs in.
Is it safe to fly right now? An MIT professor calculated the risk of air travel during the pandemic in two different flight scenarios.
Designer antibodies could help treat and prevent COVID-19
A pair of new trials will test the ability of designer antibodies to not only treat COVID-19, but also potentially prevent coronavirus infections.
Updated coronavirus vaccine list: Where we stand today
A regularly updated coronavirus vaccine list highlighting the candidates closest to receiving approval from regulators.
Coronavirus treatment update: Where we stand today
Our latest coronavirus treatment update highlights the options that appear to work, ones that might, and ones that failed to live up to their promise.
Inhaled coronavirus drug shows promise in small trial
An inhaled coronavirus drug containing interferon beta decreased patients’ chances of becoming severely ill by 79%, according to its creator.
Remote therapy is as effective as face-to-face, for depression
The pandemic has therapists' couches off limits. A new study finds that remote therapy may be as effective for depression as face-to-face, so I gave it a try.
Oxford COVID-19 vaccine triggers strong immune response
An Oxford COVID-19 vaccine triggered the creation of antibodies and T cells in trial participants, according to promising results published in The Lancet.